(Total Views: 533)
Posted On: 10/27/2021 3:52:53 PM
Post# of 153820
Re: Borel Fields #108785
The RTF letter does in fact mention syringes:
So, he was correct to mention this as a problem. But, who knows what Amarex told him as to emphasis of which was the largest problem.
Quote:
D. Device-Related Issues
No data from studies conducted with the drug in the device were included in the submission, and no information is included on the manufacturer of the syringe and needles.
So, he was correct to mention this as a problem. But, who knows what Amarex told him as to emphasis of which was the largest problem.
(5)
(0)
